Skip to main content
Equibles
NUS logo

NUS · Nu Skin Enterprises, Inc. · Documents

Track NUS — free

Use NUS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NUS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.94 +0.24 (+5.11%) Play latest call Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$238.03M
Shares
48.68M
Volume · Nov 4 643.37K Avg daily vol (3M) 530.69K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $1.49B down 14.3% 10-K filed Feb 13, 2026 Quarterly report FY2026 Q2 Revenue $320.11M down 17.1% 10-Q filed Aug 10, 2026 Latest results Financial results 8-K filed Aug 10, 2026 Earnings call Q2 2026 earnings call Held Aug 10, 2026
2026
Aug 10
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $320.11M ▼ 17.1% Net loss $249.8M Diluted EPS -$5.14
May 8
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $320.61M ▼ 12.0% Net income $1.84M ▼ 98.3% Diluted EPS $0.04 ▼ 98.1%
Apr 3
Proxy statement DEF 14A Meeting May 28, 2026
Proxy statement AI summary on its way
Feb 13
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $1.49B ▼ 14.3% Net income $160.2M Diluted EPS $3.18
2025
Nov 7
Quarterly report 10-Q FY2025 Q3, ended Sep 30
Quarterly report for FY2025 Q3
Revenue $364.21M ▼ 15.3% Net income $17.08M ▲ 105.7% Diluted EPS $0.34 ▲ 100.0%
Feb 14
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $1.73B ▼ 12.0% Net loss $146.59M Diluted EPS -$2.95
2024
Showing 1–50 of 135 documents
Key facts CIK 1021561 CUSIP 67018T105 13F (30d) 53 filings 40 filers Visit website Investor relations